1
Quist, S. W., Postma, A. J., Myrén, K. J., de Jong, L. A., Postma, M. J.
Veröffentlicht in: Quist , S W , Postma , A J , Myrén , K J , de Jong , L A & Postma , M J 2023 , ' Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands ' , European Journal of Health Economics . https://doi.org/10.1007/s10198-022-01556-5;
2023
Veröffentlicht in: Quist , S W , Postma , A J , Myrén , K J , de Jong , L A & Postma , M J 2023 , ' Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands ' , European Journal of Health Economics . https://doi.org/10.1007/s10198-022-01556-5;
2023
2
Darwish Murad, S. (Sarwa), Plessier, A. (Aurelie), Hernandez-Guerra, M. (Manuel), Fabris, F. (Federica Margherita), Eapen, C.E. (Chundamannil Eapen), Bahr, M.J. (Matthias), Trebicka, J. (Jonel), Morard, I. (Isabelle), Lasser, L. (Luc), Heller, J. (Jörg), Hadengue, A. (Antoine), Langlet, P. (Philippe), Miranda, H. (Helena), Primignani, M. (Massimo), Elias, E. (Elwyn), Leebeek, F.W.G. (Frank), Rosendaal, F.R. (Frits), Garcia-Pagan, J.C. (Juan Carlos), Valla, D.C. (Dominique Charle), Janssen, H.L.A. (Harry)
2009
2009
3